$1.68 Earnings Per Share Expected for CME Group (CME) This Quarter

Brokerages expect CME Group (NASDAQ:CME) to report earnings of $1.68 per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for CME Group’s earnings, with estimates ranging from $1.61 to $1.79. CME Group reported earnings per share of $1.23 during the same quarter last year, which would indicate a positive year over year growth rate of 36.6%. The firm is expected to issue its next earnings results on Tuesday, August 7th.

On average, analysts expect that CME Group will report full year earnings of $6.79 per share for the current fiscal year, with EPS estimates ranging from $6.60 to $6.96. For the next fiscal year, analysts anticipate that the business will report earnings of $6.99 per share, with EPS estimates ranging from $6.85 to $7.25. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research firms that that provide coverage for CME Group.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Thursday, April 26th. The financial services provider reported $1.86 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.85 by $0.01. CME Group had a return on equity of 8.48% and a net margin of 111.45%. The company had revenue of $1.10 billion for the quarter, compared to analyst estimates of $1.12 billion. During the same quarter last year, the company posted $1.22 EPS. The company’s revenue for the quarter was up 18.4% compared to the same quarter last year.

CME has been the topic of several recent analyst reports. Berenberg Bank initiated coverage on CME Group in a research note on Thursday, January 25th. They issued a “hold” rating and a $170.00 price target on the stock. Citigroup reiterated a “buy” rating and issued a $172.00 price target (up previously from $155.00) on shares of CME Group in a research note on Monday, January 29th. Sandler O’Neill reiterated a “buy” rating and issued a $175.00 price target on shares of CME Group in a research note on Friday, February 2nd. Barclays raised their price objective on CME Group from $170.00 to $175.00 and gave the company an “overweight” rating in a report on Friday, February 2nd. Finally, Bank of America raised their price objective on CME Group from $173.00 to $175.00 and gave the company a “buy” rating in a report on Friday, February 2nd. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $165.57.

Shares of CME Group traded down $0.44, hitting $160.94, during midday trading on Thursday, according to MarketBeat.com. The company’s stock had a trading volume of 34,082 shares, compared to its average volume of 1,530,160. CME Group has a one year low of $116.35 and a one year high of $171.71. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.04 and a current ratio of 1.04. The firm has a market cap of $54.24 billion, a price-to-earnings ratio of 33.59, a PEG ratio of 2.24 and a beta of 0.57.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 25th. Investors of record on Friday, June 8th will be issued a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a dividend yield of 1.74%. The ex-dividend date of this dividend is Thursday, June 7th. CME Group’s dividend payout ratio (DPR) is 58.70%.

In related news, CFO John W. Pietrowicz sold 2,500 shares of the firm’s stock in a transaction on Tuesday, April 10th. The stock was sold at an average price of $161.02, for a total transaction of $402,550.00. Following the sale, the chief financial officer now owns 34,957 shares of the company’s stock, valued at approximately $5,628,776.14. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 0.45% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CME. Comerica Bank lifted its holdings in CME Group by 0.4% during the 4th quarter. Comerica Bank now owns 84,159 shares of the financial services provider’s stock worth $13,044,000 after buying an additional 313 shares during the period. D.A. Davidson & CO. lifted its holdings in CME Group by 1.3% during the 1st quarter. D.A. Davidson & CO. now owns 26,673 shares of the financial services provider’s stock worth $4,314,000 after buying an additional 350 shares during the period. Daiwa Securities Group Inc. lifted its holdings in CME Group by 2.5% during the 4th quarter. Daiwa Securities Group Inc. now owns 14,590 shares of the financial services provider’s stock worth $2,131,000 after buying an additional 362 shares during the period. Thrivent Financial for Lutherans lifted its holdings in CME Group by 2.7% during the 1st quarter. Thrivent Financial for Lutherans now owns 14,201 shares of the financial services provider’s stock worth $2,297,000 after buying an additional 377 shares during the period. Finally, BB&T Securities LLC lifted its holdings in CME Group by 8.7% during the 4th quarter. BB&T Securities LLC now owns 4,852 shares of the financial services provider’s stock worth $708,000 after buying an additional 388 shares during the period. 82.12% of the stock is currently owned by institutional investors.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply